Effects of the GLP‐1 Agonist Exendin‐4 on Intravenous Ethanol Self‐Administration in Mice
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: Glucagon‐like peptide 1 (GLP‐1) receptor agonists have been shown to decrease ethanol (EtOH) drinking in rodent assays. The GLP‐1 system also powerfully modulates food and fluid intake, gastrointestinal functions, and metabolism. To begin to understand the neurobiological mechanisms by which GLP‐1 receptor ligands may be able to control EtOH intake, it is important to ascertain whether they can modulate the direct reinforcing effects of EtOH, without the confound of effects on ingestive behaviors generally. Methods: We trained experimentally naïve, free‐fed C57 BL/6J mice to self‐administer EtOH intravenously. Once stable EtOH intake was acquired, we tested the effect of acute pretreatment with the GLP‐1 receptor agonist Exendin‐4. Effect of Exendin‐4 on operant behavior reinforced by a palatable liquid food was similarly evaluated as a control. Results: Intravenous EtOH functioned as a positive reinforcer in over half the mice tested. In mice that acquired self‐administration, EtOH intake was high, indeed, reaching toxic doses; 3.2 μ g/kg Exendin‐4 decreased intravenous EtOH intake by at least 70%, but had no significant effect on food‐maintained operant responding. Conclusions: This experiment produced 2 main conclusions. First, although technically challenging and yielding only moderate throughput, the intravenous self‐administration procedure in mice is feasible, and sensitive to pharmacological manipulations. Second, GLP‐1 receptor agonists can powerfully attenuate voluntary EtOH intake by directly modulating the reinforcing effects of EtOH. These findings support the potential usefulness of GLP‐1 receptor ligands in the treatment of alcohol use disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515 · cited 1×
“GLP-1- producing neurons of the nucleus of the solitary tract project directly to the VTA and the shell and core regions of the nucleus accumbens (Rinaman, 2010; Alhadeff et al., 2012).”
BackgroundGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 1×
“GLP-1 is also produced in the brain, and GLP-1 receptors are expressed in brain regions important in substance use disorders, such as the ventral tegmental area (VTA) and nucleus accumbens (Göke et al. 1995; Merchenthaler et al., 1999; Cork et al., 2015).”
BackgroundGlucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6326-11.2012 · Cited by 414 · cited 4×
“GLP-1 receptor agonists decreased conditioned place preference to ethanol, sweet foods, nicotine, cocaine and amphetamine (Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf et al., 2016), and…”
BackgroundInfluentialSelf‐administration of drugs in animals and humans as a model and an investigative tool
Panlilio, L. V., & Goldberg, S. R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02011.x · Cited by 322 · cited 1×
“Intravenous selfadministration (IVSA) in laboratory animals is a procedure for measuring the immediate reinforcing effects of drugs, i.e., active drug taking behavior, and is frequently used as an “animal model” of human drug abuse (Panlilio and Goldberg, 2007).”
BackgroundRinaman, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.059 · Cited by 311 · cited 1×
“GLP-1- producing neurons of the nucleus of the solitary tract project directly to the VTA and the shell and core regions of the nucleus accumbens (Rinaman, 2010; Alhadeff et al., 2012).”
BackgroundKanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273 · cited 2×
“…effects on food and fluid intake are at least partly centrally mediated (TangChristensen et al., 1996; Turton et al., 1996; Baggio et al., 2004; Kanoski et al., 2012; Dickson et al., 2012; McKay et al., 2014), and may thus share common neurobiological mechanisms with the effects on ethanol…”
BackgroundControversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript rely on subjective/conditioned effects of abused substances (Haney and Spealman, 2008).”
BackgroundThe glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., & Jerlhag, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.009 · Cited by 207 · cited 5×
“GLP-1 receptor agonists decreased conditioned place preference to ethanol, sweet foods, nicotine, cocaine and amphetamine (Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf…”
BackgroundInfluentialRichard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119034 · Cited by 168 · cited 1×
“…(Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf et al., 2016), and also blunted increases in extracellular striatal dopamine induced by ethanol, nicotine, or stimulants…”
BackgroundEgecioglu, E., Engel, J. A., & Jerlhag, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077284 · Cited by 158 · cited 5×
“GLP-1 receptor agonists decreased conditioned place preference to ethanol, sweet foods, nicotine, cocaine and amphetamine (Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf…”
BackgroundInfluentialSuchankova, P., Yan, J., Schwandt, M. L., Stangl, B. L., Caparelli, E. C., Momenan, R., Jerlhag, E., Engel, J. A., Hodgkinson, C. A., Egli, M., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.68 · Cited by 146 · cited 5×
“In rodent studies, GLP-1 receptor agonists were shown to reduce ethanol drinking, although the effects were sometimes modest, or only observed in high-drinking subjects (e.g., made dependent on ethanol using vapor exposure, or spontaneously alcohol-preferring; Egecioglu et al., 2013a; Shirazi et al., 2013; Suchankova…”
BackgroundInfluentialAlhadeff, A. L., & Grill, H. J. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00179.2014 · Cited by 111 · cited 1×
“…cocaine and amphetamine (Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf et al., 2016), and also blunted increases in extracellular striatal dopamine induced by…”
BackgroundBrain activation following peripheral administration of the GLP-1 receptor agonist exendin-4
Baraboi, E.-D., St-Pierre, D. H., Shooner, J., Timofeeva, E., & Richard, D. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00424.2010 · Cited by 79 · cited 1×
“Doses of Exendin-4 were selected based on published studies, and on pilot studies in our laboratory (Baraboi et al., 2011; Williams et al., 2011).”
MethodMcKay, N. J., Galante, D. L., & Daniels, D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3267-14.2014 · Cited by 55 · cited 2×
“GLP-1 receptormediated effects on food and fluid intake are at least partly centrally mediated (TangChristensen et al., 1996; Turton et al., 1996; Baggio et al., 2004; Kanoski et al., 2012; Dickson et al., 2012; McKay et al., 2014), and may thus share common neurobiological mechanisms with the effects on ethanol drink…”
Background
Cited by
The dopamine motive system: implications for drug and food addiction
Volkow, N. D., Wise, R. A., & Baler, R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.130 · Cited by 939
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“However, the fact that exenatide also reduced intravenous self-administration of alcohol (Sørensen et al., 2016) and GLP-1 receptor agonists reduced rewarding effects of alcohol injections as measured by place conditioning (Egecioglu, Steensland, et al., 2013; Shirazi et al., 2013; Vallöf et al.,…”
BackgroundSelf-citationSemaglutide reduces alcohol intake and relapse-like drinking in male and female rats
Aranäs, C., Edvardsson, C. E., Shevchouk, O. T., Zhang, Q., Witley, S., Blid Sköldheden, S., Zentveld, L., Vallöf, D., Tufvesson-Alm, M., & Jerlhag, E. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104642 · Cited by 158
Jerlhag, E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1063033 · Cited by 80
“However, this is unlikely, as Ex4 reduces intravenous self-administration of alcohol in male mice (Sorensen et al., 2016) and the GLP-1R agonist does not reduce water intake.”
BackgroundBornebusch, A. B., Fink-Jensen, A., Wörtwein, G., Seeley, R. J., & Thomsen, M. (2019) · eneuro · doi:10.1523/eneuro.0443-18.2019 · Cited by 72
Self-citation
Metadata
- Authors
- Sørensen, G., Caine, S. B., & Thomsen, M.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2016-08-31
- Volume
- 40
- Issue
- 10
- Pages
- 2247-2252
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W2514621876
- Cited by
- 69
- References
- 18
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.